In the context of joint disease, its role is becoming clearer; IL-11 and its receptor are upregulated in the synovium of patients with osteoarthritis and rheumatoid arthritis, which are implicated in promoting inflammation and tissue degradation [21,22]. This evidence concerns the gene IL11 and osteoarthritis.